Retraction of an intraperitoneal chemotherapy port: A case report and literature review

International Journal of Gynecological Cancer

Volumn 17, Issue 5, 2007, Pages 1131-1133

  Pendergrass, M ^a   Gordinier, M E ^a   Parker, L P ^a   Metzinger, D S ^a   Helm, C W ^a,b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b James Graham Brown Cancer Center   (United States)

Author keywords

Intraperitoneal chemotherapy; Ovarian cancer; Peritoneal access device

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DACRON; PACLITAXEL; SILASTIC;

ABDOMINAL WALL; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER OCCLUSION; CYTOREDUCTIVE SURGERY; DEVICE; FEMALE; HUMAN; INFECTION RISK; MEDICAL LITERATURE; OVARY CARCINOMA; PERITONEAL CATHETER; PERITONEAL CAVITY; PERITONEUM; PRIORITY JOURNAL; RISK REDUCTION; SUBCUTANEOUS TISSUE;

ANTINEOPLASTIC AGENTS; CARCINOMA; CATHETERIZATION; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL CAVITY;

EID: 34548773951     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00910.x     Document Type: Article

References (9)

1. Alberts DS, Liu PY, Hannigan EV et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [see comment]. N Engl J Med 1996 335 : 1950 5.
2. Markman M, Bundy BN, Alberts DS et al. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group [see comment]. J Clin Oncol 2001 19 : 1001 7.
3. Armstrong DK, Bundy BN, Wenzel L et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006 354 : 34 43.
4. Jenkins J, Sugarbaker PH, Gianola FJ et al. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet 1982 154 : 858 62.
5. Piccart MJ, Speyer JL, Markman M et al. Intraperitoneal chemotherapy: technical experience at five institutions. Semin Oncol 1985 12 : 90 6.
6. Braly P, Doroshow J, Hoff S. Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis. Gynecol Oncol 1986 25 : 319 33.
7. Rubin SC, Hoskins WJ, Markman M et al. Long-term access to the peritoneal cavity in ovarian cancer patients. Gynecol Oncol 1989 33 : 46 8.
8. Davidson SA, Rubin SC, Markman M et al. Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system. Gynecol Oncol 1991 41 : 101 6.
9. Walker JL, Armstrong DK, Huang HQ et al. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III and primary peritoneal cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2006 100 : 27 32.